Insider Buying: Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Director Buys 100,000 Shares of Stock

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Director Anthony James Culverwell acquired 100,000 shares of the business’s stock in a transaction on Monday, December 23rd. The shares were purchased at an average price of $0.45 per share, with a total value of $45,000.00. Following the completion of the purchase, the director now owns 100,317 shares in the company, valued at $45,142.65. This represents a 31,545.74 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website.

Quoin Pharmaceuticals Price Performance

Shares of NASDAQ:QNRX opened at $0.55 on Friday. Quoin Pharmaceuticals, Ltd. has a 1 year low of $0.43 and a 1 year high of $6.18. The firm has a market capitalization of $2.78 million, a PE ratio of -0.14 and a beta of 1.79. The business’s 50 day moving average price is $0.68 and its 200-day moving average price is $0.63.

Quoin Pharmaceuticals Company Profile

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma.